Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19
Andrea Cortegiani, Mariachiara Ippolito, Giulia Ingoglia, et al.
Journal of Critical Care (2020) Vol. 59, pp. 176-190
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

COVID-19: Discovery, diagnostics and drug development
Tarik Asselah, David Durantel, Éric Pasmant, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 168-184
Open Access | Times Cited: 410
Traditional Herbal Medicine Candidates as Complementary Treatments for COVID-19: A Review of Their Mechanisms, Pros and Cons
Rhea Veda Nugraha, Hastono Ridwansyah, Mohammad Ghozali, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 201
Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination
Carlos Augusto Morales-Paredes, Joan Manuel Rodríguez-Díaz, Nuria Boluda Botella
The Science of The Total Environment (2021) Vol. 814, pp. 152691-152691
Open Access | Times Cited: 151
One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview
Matheus Negri Boschiero, Camila Vantini Capasso Palamim, Manoela Marques Ortega, et al.
Annals of Global Health (2021) Vol. 87, Iss. 1, pp. 44-44
Open Access | Times Cited: 85
Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries
Ali J. Marian
Cardiovascular Pathology (2020) Vol. 50, pp. 107278-107278
Open Access | Times Cited: 75
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry
Cláudia Diniz Lopes Marques, Adriana María Kakehasi, Marcelo Medeiros Pinheiro, et al.
RMD Open (2021) Vol. 7, Iss. 1, pp. e001461-e001461
Open Access | Times Cited: 68
Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2723-2723
Open Access | Times Cited: 63
Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?
Émile Lévy, Edgard Delvin, Valérie Marcil, et al.
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 4, pp. E689-E708
Open Access | Times Cited: 65
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
Bianza Moïse Bakadia, Feng He, Tiatou Souho, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111008-111008
Open Access | Times Cited: 53
Hydroxychloroquine Adsorption in Aqueous Medium Using Clinoptilolite Zeolite
Ramiro Picoli Nippes, Paula Derksen Macruz, Luiza Carla Augusto Molina, et al.
Water Air & Soil Pollution (2022) Vol. 233, Iss. 8
Open Access | Times Cited: 33
Emergency Nursing Care of Patients With Novel Coronavirus Disease 2019
Katie Deitrick, Jourdan Adams, Joshua Davis
Journal of Emergency Nursing (2020) Vol. 46, Iss. 6, pp. 748-759
Open Access | Times Cited: 41
Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis
Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, et al.
Tropical Medicine and Infectious Disease (2020) Vol. 5, Iss. 4, pp. 180-180
Open Access | Times Cited: 39
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 33
Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
A. J. J. Lammers, Richard M. Brohet, R.E.P. Theunissen, et al.
International Journal of Infectious Diseases (2020) Vol. 101, pp. 283-289
Open Access | Times Cited: 38
Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
Alaa Rashad, Sherif Abdo Mousa, Hanaa Nafady‐Hego, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection
Subhajit Maity, Abhik Saha
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 28
Cardiopulmonary resuscitation in prone position: A scoping review
Alessandra Moscarelli, Pasquale Iozzo, Mariachiara Ippolito, et al.
The American Journal of Emergency Medicine (2020) Vol. 38, Iss. 11, pp. 2416-2424
Open Access | Times Cited: 31
Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio/chemoinformatics tools
Rania M. Hathout, Sherihan G. AbdelHamid, Abdelkader A. Metwally
Informatics in Medicine Unlocked (2020) Vol. 21, pp. 100446-100446
Open Access | Times Cited: 27
Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic
Joshua D. Brown, Scott Martin Vouri, Todd M. Manini
Research in Social and Administrative Pharmacy (2020) Vol. 17, Iss. 8, pp. 1478-1482
Open Access | Times Cited: 27
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs
Nathalie Vernaz, Thomas Agoritsas, Alexandra Calmy, et al.
Schweizerische medizinische Wochenschrift (2020) Vol. 150, Iss. 5153, pp. w20446-w20446
Open Access | Times Cited: 27
Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
Paul Eze, Kenechukwu Mezue, Chidozie Nduka, et al.
PubMed (2021) Vol. 11, Iss. 1, pp. 93-107
Closed Access | Times Cited: 23
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
Ramesh K. Goyal, Jaseela Majeed, Rajiv Kumar Tonk, et al.
Reviews in Cardiovascular Medicine (2020) Vol. 21, Iss. 3, pp. 365-365
Open Access | Times Cited: 24
Treatment and prognosis of COVID‑19: Current scenario and prospects (Review)
Xuemei Li, Tao Li, Huihui Wang
Experimental and Therapeutic Medicine (2020) Vol. 20, Iss. 6, pp. 1-1
Open Access | Times Cited: 24
Immunomodulatory therapies for COVID-19
Poonam Mathur, Shyamasundaran Kottilil
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Pharmacological management of COVID-19 in type 2 diabetes
Antonio Ceriello, Francesco Prattichizzo
Journal of Diabetes and its Complications (2021) Vol. 35, Iss. 7, pp. 107927-107927
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top